Trials / Not Yet Recruiting
Not Yet RecruitingNCT07323134
The Effect of Semaglutide on the Intestinal Flora in Obesity
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
For obese individuals, semaglutide treatment was adopted. By using multi-omics techniques such as fecal metagenomic sequencing and based on in vitro strain screening platforms, the effects and specific mechanisms of semaglutide on the intestinal flora of obese patients were clarified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Semaglutide Injection | Semaglutide Injection |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2026-01-07
- Last updated
- 2026-01-07
Source: ClinicalTrials.gov record NCT07323134. Inclusion in this directory is not an endorsement.